Glaxo Kidney Cancer Drug Has Liver Risk, FDA Says - Bloomberg PDF Print
BloombergGlaxo's pazopanib may be “associated with a significant risk” of severe liver injury in patients with advanced renal cell carcinoma, the most-common form of ...FDA Staff Express Safety Concerns About GlaxoSmithKline's Votrient For Kidney

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129